| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1Department of Medicine, 2Neuroscience Program, and 3Cell and Molecular Biology Program, Michigan State University, East Lansing, Michigan; and 4Department of Pharmacology, Guangzhou Medical College, Guangzhou, China
Submitted 9 February 2007 ; accepted in final form 18 June 2007
Although the transient receptor potential vanilloid type 1 (TRPV1)-containing afferent nerve fibers are widely distributed in the heart, the relationship between TRPV1 function and cardiac ischemic preconditioning (PC) has not been well defined. Using TRPV1 knockout mice (TRPV1–/–), we studied the role of TRPV1 in PC-induced myocardial protection. Hearts of gene-targeted TRPV1-null mutant (TRPV1–/–) or wild-type (WT) mice were Langendorffly perfused in the presence or absence of CGRP8-37, a selective calcitonin gene-related peptide (CGRP) receptor antagonist; or RP-67580, a selective neurokinin-1 receptor antagonist when hearts were subjected to three 5-min periods of ischemia PC followed by 30 min of global ischemia and 40 min of reperfusion (I/R). PC before I/R decreased left ventricular (LV) end-diastolic pressure and increased LV developed pressure, coronary flow (CF), peak-positive maximum rate of rise of LV pressure in WT mice (PC-WT) compared with PC-TRPV1–/–, TRPV1–/–, or WT hearts (P < 0.05), and PC also decreased LV end-diastolic pressure in PC-TRPV1–/– compared with TRPV1–/–. CGRP8-37 or RP-67580 abolished PC-induced protection in WT but not TRPV1–/– hearts (P < 0.05). Moreover, PC decreased lactate dehydrogenase release and infarct size in PC-WT compared with PC-TRPV1–/–, TRPV1–/–, or WT hearts, and it also lowered these parameters in PC-TRPV1–/– compared with TRPV1–/– hearts (P < 0.05). Radioimmunoassay showed that the release of substance P and CGRP after PC was higher in WT hearts than in TRPV1–/– hearts (P < 0.05), which was attenuated by capsazepine in WT but not TRPV1–/– hearts. Thus PC-induced protection of the heart was impaired in TRPV1–/– hearts, indicating that TRPV1 contributes to the beneficial effects of preconditioning against I/R injury through release substance P and CGRP.
transient receptor potential vanilloid type 1; ischemia-reperfusion; substance P; calcitonin gene-related peptide
This article has been cited by other articles:
|
|
 |
|
  C. P. Regan, G. L. Stump, S. A. Kane, and J. J. Lynch Jr. Calcitonin Gene-Related Peptide Receptor Antagonism Does Not Affect the Severity of Myocardial Ischemia during Atrial Pacing in Dogs with Coronary Artery Stenosis J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huang, J. Rubinstein, A. R. Prieto, L. V. Thang, and D. H. Wang Transient Receptor Potential Vanilloid Gene Deletion Exacerbates Inflammation and Atypical Cardiac Remodeling After Myocardial Infarction Hypertension, February 1, 2009; 53(2): 243 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Reichelt, L. Willems, B. A. Hack, J. N. Peart, and J. P. Headrick Cardiac and coronary function in the Langendorff-perfused mouse heart model Exp Physiol, January 1, 2009; 94(1): 54 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zhong and D. H. Wang N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1 Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H728 - H735. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
